Letter abstract
Nature Medicine 14, 966 - 972 (2008)
Published online: 24 August 2008 | doi:10.1038/nm.1860
Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption
Eun-Ju Chang1, Jeongim Ha1, Frank Oerlemans2, You Jin Lee3, Soo Woong Lee4, Jiyoon Ryu1, Hyung Joon Kim1, Youngkyun Lee1, Hyun-Man Kim1, Je-Yong Choi5, Jin Young Kim6, Chan Soo Shin7, Youngmi Kim Pak8, Sakae Tanaka9, Bé Wieringa2, Zang Hee Lee1 & Hong-Hee Kim1
Osteoclasts differentiate from precursor cells of the monocyte-macrophage lineage and subsequently become activated to be competent for bone resorption through programs primarily governed by receptor activator of nuclear factor-
B ligand in cooperation with macrophage colony–stimulating factor1, 2, 3. Proteins prominently expressed at late phases of osteoclastogenesis and with a supportive role in osteoclast function are potential therapeutic targets for bone-remodeling disorders. In this study, we used a proteomics approach to show that abundance of the brain-type cytoplasmic creatine kinase (Ckb) is greatly increased during osteoclastogenesis. Decreasing Ckb abundance by RNA interference or blocking its enzymatic activity with a pharmacological inhibitor, cyclocreatine, suppressed the bone-resorbing activity of osteoclasts grown in vitro via combined effects on actin ring formation, RhoA GTPase activity and vacuolar ATPase function. Activities of osteoclasts derived from Ckb-/- mice were similarly affected. In vivo studies showed that Ckb-/- mice were better protected against bone loss induced by ovariectomy, lipopolysaccharide challenge or interleukin-1 treatment than wild-type controls. Furthermore, administration of cyclocreatine or adenoviruses harboring Ckb small hairpin RNA attenuated bone loss in rat and mouse models. Our findings establish an important role for Ckb in the bone-resorbing function of osteoclasts and underscore its potential as a new molecular target for antiresorptive drug development.
- Department of Cell and Developmental Biology, Brain Korea 21, School of Dentistry, Seoul National University, 28 Yeongon-Dong, Jongno-gu, Seoul 110-749, Korea.
- Department of Cell Biology, Nijmegen Centre for Molecular Life Sciences, Radboud University Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
- Research Division, Jeonnam Biotechnology Research Center, 121 Naepyeongri, Hwasun-gun, Jeollanamdo 519-801, Korea.
- Department of Microbiology, Center for Viral Disease Research, College of Medicine, Inje University, 633-165 Gaegeum-Dong, Busanjin-gu, Busan 614-735, Korea.
- Department of Biochemistry and Cell Biology, School of Medicine and Skeletal Diseases Genome Research Center, Kyungpook National University, 101 Dong-in Dong, Jung-gu, Daegu 700-422, Korea.
- Korea Basic Science Institute, 52 Eoeun-Dong, Yusung-gu, Daejeon 305-333, Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, 28 Yeongon-Dong, Jongno-gu, Seoul 110-744, Korea.
- Age-related and Brain Disease Research Center, Department of Nanopharmaceutical and Life Sciences, Kyung Hee University, 1 Hoegi-Dong, Dongdaemun-gu, Seoul 130-701, Korea.
- Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-gu, Tokyo 113-0033, Japan.
Correspondence to: Hong-Hee Kim1 e-mail: hhbkim@snu.ac.kr
Correspondence to: Bé Wieringa2 e-mail: b.wieringa@ncmls.ru.nl
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Concrete Staved Silos for storing High-moisture BarleyNature News and Views (22 Jan 1966)
Research HighlightsNature Biotechnology News and Views (01 Sep 2008)
RESEARCH
Estrogen-dependent and C-C chemokine receptor-2?dependent pathways determine osteoclast behavior in osteoporosisNature Medicine Article (01 Apr 2009)
Vav3 regulates osteoclast function and bone massNature Medicine Article (01 Mar 2005)
See all 34 matches for Research
